Exelixis Stock Price (NASDAQ:EXEL)

Add to My Stocks
$17.92 $0.02 (0.11%) EXEL stock closing price Jan 20, 2017 (Closing)
20 JAN 2017
amigobulls logo
EXEL hand_up
EXEL vs S&P 500
Closing Price: Jan 20, 2017
$17.92 ( 0.11%)
S&P 500
2271.3 ( 0.34%)
52 Week Price Range
1 Year Return: 309.61%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Exelixis Snapshot Video

13 5 2

EXEL Stock Details

Prev Close* : $17.90
Market Cap:
Day Low: $17.64
52 Week Low: $3.55
Open: $17.92
Volume: 3070157
Day High: $18.03
52 Week High: $19.30

Latest Stock Market News

Latest Articles

Exelixis News - From Partners

EXEL Stockcharts

View EXEL PE ratio, PS ratio stocks charts and compare with peers.
EXEL Chart
Note: Compare Exelixis stock price history with the index and industry peers.

Exelixis Valuation

PS ratio (
price to sales ratio

Exelixis Returns

(return on equity)

Exelixis Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

EXEL Industry Peers

Company Price Change (%)
Qiagen (QGEN)27.640.05 (0.18%)
Dyax (DYAX)38.410 (0%)
Bristol-myers Squibb (BMY)49.236.26 (11.28%)
Merck (MRK)62.532.2 (3.65%)
Roche Holdings (RHHBY)29.190.23 (0.79%)
Sanofi (SNY)40.350.18 (0.45%)
Swedish Orphan (SWTUY)12.690.17 (1.32%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
NewLink Genetics (NLNK)11.330.54 (5%)
Argos Therapeutics (ARGS)5.050.2 (4.12%)
Halozyme Therapeutics (HALO)11.50.42 (3.79%)
BioDelivery Sciences (BDSI)1.90.05 (2.7%)
Osiris Therapeutics (OSIR)5.040.13 (2.65%)
VIVUS (VVUS)1.190.03 (2.59%)
Amarin (AMRN)2.950.07 (2.43%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jan 21, 2017
CompanyPriceChange (%)
Pluristem Therapeutics (PSTI)1.150.25 (17.86%)
Puma Biotech (PBYI)32.253.25 (9.15%)
Sangamo BioSciences (SGMO)3.650.3 (7.59%)
Five Prime Therapeutics (FPRX)43.52.58 (5.6%)
Stemline Therapeutics (STML)10.40.6 (5.45%)
Sarepta Therapeutics (SRPT)32.661.57 (4.59%)
Inovio Pharma (INO)6.280.3 (4.56%)
Top losers from Medical-Biomed-Genetics industry
* As of Jan 21, 2017

Exelixis Financial Statements

income statement20152014201320122011
Net Sales Or Revenues37.17M25.11M31.33M47.45M289.63M
Net Income-169.73M-268.54M-244.76M-147.64M75.69M
Total Operating Expense154.69M247.52M230.94M169.87M200.09M
view Exelixis, Inc. income statement
balance sheet20152014201320122011
Total Assets332.34M327.96M503.28M721.09M393.26M
Total Liabilities436.64M442.78M437.04M424.66M302.63M
Shareholders Equity-104.3M-114.82M66.23M296.43M90.63M
view Exelixis, Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-25.84M-10.27M-2.26M-8.63M-264.88M
Net Cash From (Used By) Operating Activities-141.58M-235.4M-198.77M-123.14M-159.23M
Increase (Decrease) In Prop Plant And Equipment0.89M-0.08M-2.02M-0.77M0.53M
view Exelixis, Inc. cashflow statement

Exelixis, Inc. Stock News - Partner Headlines

Exelixis Stock Message Board

Exelixis stock price ended the last trading day at 17.92. Stock price or share price can be used to find the total market value of a company. Exelixis market cap stands at 5.13B as of 20 Jan, 2017. Exelixis valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Exelixis stock price and Exelixis share price mean the same thing. 3070157 shares were traded with a closing stock price of 17.92 as of 20 Jan, 2017, as can be seen from Exelixis stock quote. One can view Exelixis stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Exelixis stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.